Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma
Katia Mariniello(Queen Mary University of London), Leonardo Guasti(Queen Mary University of London), Carles Gaston‐Massuet(Queen Mary University of London), Martin Faßnacht(University of Würzburg), Cristina L Ronchi(University of Birmingham), Celso E. Gómez-Sánchez(Universidade Federal do Estado do Rio de Janeiro), Barbara Altieri(Universitätsklinikum Würzburg), Katja Kiseljak‐Vassiliades(Johns Hopkins University), David R. Taylor(King's College Hospital NHS Foundation Trust), Emanuel Rognoni(Queen Mary University of London), Matthias Kroiß, Claudio Henrique T. Ribeiro(Boston Children's Hospital), Andrea Abate(Brescia University), James Pittaway(Queen Mary University of London), Nafis A. Rahman(Medical University of Białystok), Sandra Sigala(Brescia University), Constanze Hantel(Ludwig-Maximilians-Universität München), Jane Sosabowski(Queen Mary University of London), Tarek Abdel‐Aziz(University College Hospital), David T. Breault(Boston Children's Hospital), Irene Hadjidemetriou(Queen Mary University of London), Milena Doroszko(University of Turku), Teng‐Teng Chung(University College Hospital), Margaret E. Wierman(University of Colorado Anschutz Medical Campus), Fausto Palazzo(Hammersmith Hospital), Julie Foster(Queen Mary University of London), Laila Parvanta(St Bartholomew's Hospital), Silviu Sbiera(University of Würzburg), Kleiton Silva Borges(Boston Children's Hospital), Julie Cleaver(Queen Mary University of London), Jiang A. Lim(Queen Mary University of London), William M Drake(St Bartholomew's Hospital), Oliver Rayner(King's College Hospital), Mariangela Tamburello(Brescia University), Aimee Di Marco(Hammersmith Hospital), Gerard Ruiz‐Babot(Harvard Stem Cell Institute)
Cited by 3
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2018|927
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863